| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 1.910 | 20100301, Scala E
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 1.040 | 20120528, Patelis A
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 16.800 | 20130912, Lacerda Araujo LM
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 2.140 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Netherlands | IgE | 211 | 6.200 | 20140331, Rockmann H
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 7.410 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 7.410 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 3.2.1 - Source Sensitized (IgE) | 2014 | Singapore | IgE | 27 | 14.800 | 20140926, Thalayasingam M
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 0.000 | 20111214, Zheng YW
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 9.090 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | Singapore | IgE | 38 | 7.900 | 20140926, Thalayasingam M
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 9 | 22.220 | 20110609, Gamez C
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2014 | Italy | IgE | 40 | 22.500 | 20140916, Giuffrida MG
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 3.030 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Japan | IgE | 16 | 81.250 | 20080118, Shiomi K
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Singapore | IgE | 38 | 31.600 | 20140926, Thalayasingam M
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 36 | 63.890 | 20110609, Gamez C
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | United States | IgE | 22 | 54.540 | 20120103, Wang S
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.810 | 20120528, Patelis A
|
|
Loading...
Pen m 1
